{"id":"https://openalex.org/W2944733609","doi":"https://doi.org/10.1039/9781788016421-00386","title":"CHAPTER 14. Strategies for Safe and Targeted Delivery of MicroRNA Therapeutics","display_name":"CHAPTER 14. Strategies for Safe and Targeted Delivery of MicroRNA Therapeutics","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2944733609","doi":"https://doi.org/10.1039/9781788016421-00386","mag":"2944733609"},"language":"en","primary_location":{"id":"doi:10.1039/9781788016421-00386","doi":"https://doi.org/10.1039/9781788016421-00386","is_oa":false,"landing_page_url":"https://doi.org/10.1039/9781788016421-00386","pdf_url":null,"source":{"id":"https://openalex.org/S4210169072","display_name":"RSC drug discovery/RSC drug discovery series","issn_l":"2041-3203","issn":["2041-3203","2041-3211"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4256679659","display_name":"MicroRNAs in Diseases and Disorders"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045814208","display_name":"Sunghyun Myoung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunghyun (Sander) Myoung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082310628","display_name":"Andrea L. Kasinski","orcid":"https://orcid.org/0000-0002-9602-7827","observed_orcids":["https://orcid.org/0000-0002-9602-7827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea L. Kasinski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2807,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.89516038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":null,"issue":null,"first_page":"386","last_page":"415"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microrna-therapy","display_name":"miRNA-based therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/microrna-delivery","display_name":"microRNA delivery","score":0.9350000023841858},{"id":"https://openalex.org/keywords/targeted-delivery","display_name":"targeted delivery","score":0.6399999856948853},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.6729999780654907},{"id":"https://openalex.org/keywords/inorganic-materials","display_name":"inorganic materials","score":0.656000018119812},{"id":"https://openalex.org/keywords/minicells","display_name":"minicells","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.6940000057220459},{"id":"https://openalex.org/keywords/clinical-translation","display_name":"clinical translation","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.706262469291687},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3883158266544342},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24671673774719238},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1184968650341034},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.04802694916725159}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1039/9781788016421-00386","doi":"https://doi.org/10.1039/9781788016421-00386","is_oa":false,"landing_page_url":"https://doi.org/10.1039/9781788016421-00386","pdf_url":null,"source":{"id":"https://openalex.org/S4210169072","display_name":"RSC drug discovery/RSC drug discovery series","issn_l":"2041-3203","issn":["2041-3203","2041-3211"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1974879294","https://openalex.org/W4323075046","https://openalex.org/W7221509007","https://openalex.org/W7131625635","https://openalex.org/W4416660109","https://openalex.org/W2902867341","https://openalex.org/W3041438991","https://openalex.org/W4388898688","https://openalex.org/W2028777474","https://openalex.org/W4289111339"],"abstract_inverted_index":{"Based":[0],"on":[1],"the":[2,22,58,114,140,147,161,173],"knowledge":[3],"that":[4,39,130],"microRNAs":[5],"(miRNAs)":[6],"are":[7,15,79,175],"dysregulated":[8],"in":[9,61,84,88,151],"numerous":[10],"diseases":[11],"including":[12],"cancer,":[13],"attempts":[14],"being":[16,80,94],"explored":[17,95],"to":[18,35,57,139,164,168],"restore":[19],"or":[20],"inhibit":[21],"cytosolic":[23],"level":[24],"and":[25,42,76,82,87,106,120,156],"activity":[26,41],"of":[27,53,113,116,133,160],"clinically":[28,54],"relevant":[29,55,123],"miRNAs.":[30],"Although":[31],"various":[32],"chemical":[33],"modifications":[34],"small":[36],"RNA":[37,107],"sequences":[38],"improve":[40],"stability,":[43],"as":[44,46,127],"well":[45],"reduce":[47],"toxicity,":[48],"have":[49,125],"been":[50],"identified,":[51],"delivery":[52,71,98],"miRNAs":[56,124,153],"proper":[59],"tissue":[60],"vivo":[62,89],"remains":[63],"a":[64],"challenge.":[65],"To":[66],"overcome":[67,131,165],"this":[68],"challenge,":[69],"innovative":[70],"methods":[72],"using":[73],"lipid-based,":[74],"polymer-based,":[75],"inorganic-material-based":[77],"vehicles":[78],"developed":[81],"tested":[83],"several":[85],"cell-based":[86],"systems.":[90],"Additional":[91],"unconventional":[92],"technologies":[93],"for":[96],"miRNA":[97,170],"include":[99],"exosomal":[100],"delivery,":[101,103],"ligand-mediated":[102],"mini":[104],"cells,":[105],"prodrugs.":[108],"Herein,":[109],"we":[110],"present":[111],"some":[112,132,159],"limitations":[115],"conventional":[117],"cancer":[118],"therapeutics":[119,171],"how":[121],"therapeutically":[122],"emerged":[126],"novel":[128],"agents":[129],"these":[134,166],"challenges.":[135],"Attention":[136],"is":[137],"given":[138],"issues":[141],"currently":[142],"plaguing":[143],"miRNA-based":[144],"therapies,":[145],"especially":[146],"critical":[148],"barriers":[149,167],"involved":[150],"delivering":[152],"safely,":[154],"specifically,":[155],"efficiently.":[157],"Importantly,":[158],"current":[162],"efforts":[163],"advance":[169],"into":[172],"clinic":[174],"discussed.":[176]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2019-05-16T00:00:00"}